As shown in Figure 3, EGFR aberrations including gene amplification and EGFRvIII mutation, PTEN mutation, as well as TOP2A, RRM1 and TS overexpression were significantly more prevalent in GBM than grade III astrocytomas. This evidence concerns the gene EGFR and glioblastoma.